JP2004532265A5 - - Google Patents

Download PDF

Info

Publication number
JP2004532265A5
JP2004532265A5 JP2003500072A JP2003500072A JP2004532265A5 JP 2004532265 A5 JP2004532265 A5 JP 2004532265A5 JP 2003500072 A JP2003500072 A JP 2003500072A JP 2003500072 A JP2003500072 A JP 2003500072A JP 2004532265 A5 JP2004532265 A5 JP 2004532265A5
Authority
JP
Japan
Prior art keywords
methyl
formula
compound according
compound
trifluoromethylphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003500072A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004532265A (ja
Filing date
Publication date
Priority claimed from GBGB0113232.3A external-priority patent/GB0113232D0/en
Application filed filed Critical
Publication of JP2004532265A publication Critical patent/JP2004532265A/ja
Publication of JP2004532265A5 publication Critical patent/JP2004532265A5/ja
Pending legal-status Critical Current

Links

JP2003500072A 2001-05-31 2002-05-29 チアゾールpparリガンドおよびその多形体の調製方法 Pending JP2004532265A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0113232.3A GB0113232D0 (en) 2001-05-31 2001-05-31 Chemical process
PCT/EP2002/005884 WO2002096893A1 (en) 2001-05-31 2002-05-29 Process for preparing a thialzole ppar-ligand and polymorphs thereof

Publications (2)

Publication Number Publication Date
JP2004532265A JP2004532265A (ja) 2004-10-21
JP2004532265A5 true JP2004532265A5 (https=) 2005-12-22

Family

ID=9915637

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003500072A Pending JP2004532265A (ja) 2001-05-31 2002-05-29 チアゾールpparリガンドおよびその多形体の調製方法

Country Status (22)

Country Link
US (1) US7244849B2 (https=)
EP (1) EP1395572B1 (https=)
JP (1) JP2004532265A (https=)
KR (1) KR20040007631A (https=)
CN (1) CN1551871A (https=)
AT (1) ATE315556T1 (https=)
AU (1) AU2002317764B2 (https=)
BR (1) BR0209892A (https=)
CA (1) CA2448101A1 (https=)
CO (1) CO5540298A2 (https=)
CZ (1) CZ20033256A3 (https=)
DE (1) DE60208682T2 (https=)
ES (1) ES2256493T3 (https=)
GB (1) GB0113232D0 (https=)
HU (1) HUP0400117A3 (https=)
IL (1) IL158641A0 (https=)
MX (1) MXPA03010943A (https=)
NO (1) NO20035313L (https=)
NZ (1) NZ529486A (https=)
PL (1) PL367114A1 (https=)
WO (1) WO2002096893A1 (https=)
ZA (1) ZA200308570B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105551B2 (en) * 2000-12-20 2006-09-12 Smithkline Beecham Corporation Thiazole derivatives for treating PPAR related disorders
EP1517882A1 (en) 2002-06-19 2005-03-30 Eli Lilly And Company Amide linker peroxisome proliferator activated receptor modulators
TW200400816A (en) 2002-06-26 2004-01-16 Lilly Co Eli Tricyclic steroid hormone nuclear receptor modulators
AU2003261935A1 (en) 2002-09-06 2004-03-29 Takeda Pharmaceutical Company Limited Furan or thiophene derivative and medicinal use thereof
EA010422B1 (ru) 2003-08-01 2008-08-29 Янссен Фармацевтика Н.В. Замещённые индол-о-глюкозиды
WO2005097076A2 (en) * 2004-04-09 2005-10-20 Smithkline Beecham Corporation Low dose pharmaceutical products
EP2044042A2 (en) * 2006-01-10 2009-04-08 SmithKline Beecham Corporation Polymorphic forms of { 2-methyl-4- [4-methyl-2- (trifluoromethylphenyl) thiazol-5-methylthiol phenoxy}-acetic acid
WO2012168948A2 (en) * 2011-06-06 2012-12-13 Hetero Research Foundation Process for febuxostat

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE451346T1 (de) * 1998-03-10 2009-12-15 Ono Pharmaceutical Co Carbonsäurederivate und medikamente die diese als aktiven wirkstoff enthalten
PE20011010A1 (es) * 1999-12-02 2001-10-18 Glaxo Group Ltd Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
US7091225B2 (en) * 2000-12-20 2006-08-15 Smithkline Beecham Corporation Substituted oxazoles and thiazoles as hPPAR alpha agonists
GB0111523D0 (en) * 2001-05-11 2001-07-04 Glaxo Group Ltd Chemical compounds
GB0113233D0 (en) * 2001-05-31 2001-07-25 Glaxo Group Ltd Chemical compounds

Similar Documents

Publication Publication Date Title
JP2021063088A5 (https=)
JP2006182786A5 (https=)
JP2012532874A5 (https=)
JP2002540156A (ja) 抗ウイルス治療用チアジアゾリルウレアまたはチオウレア誘導体
JP2005537234A5 (https=)
JP2002520416A5 (https=)
GB0211649D0 (en) Organic compounds
JP2020507589A5 (https=)
JP2008509191A5 (https=)
EP2298757A3 (en) Urea compounds active as vanilloid receptor antagonist for the treatment of pain
JP2007501809A5 (https=)
JP2003506354A5 (https=)
JP2005501120A5 (https=)
JP2005524648A5 (https=)
RU2004136853A (ru) (s)-4-амино-5-хлор-2-метокси-n-[1-[1-(2-тетрагидрофурилкарбонил)-4- пиперидини лметил]-4-пиперидинил]бензамид, способ его получения, содержащая его фармацевтическая композиция и промежуточное соединение для его получения
JP2005508337A5 (https=)
RU2007101653A (ru) Производные 1-азабицикло[3.3.1]нонанов
JP2005508955A5 (https=)
JP2003522198A5 (https=)
JP2004532265A5 (https=)
JP2005513014A5 (https=)
CN1212625A (zh) 用于治疗呼吸系统疾病的咖啡因和氯马斯汀
JP2004510750A5 (https=)
JP2004525178A5 (https=)
JP2005516898A5 (https=)